GENEVA, SWITZERLAND (4 APRIL 2002) - Results from the first head-to-head study comparing ARICEPT® (donepezil HCl tablets) and Reminyl® (galantamine HBr tablets) demonstrated significantly greater ...

Eisai got an FDA untitled letter for two Aricept TV ads that the agency said overstate the efficacy of the drug. The ads, “Beach” and “Garden,” feature women recounting seeing the signs of advancing ...

The patent wall protecting Eisai‘s (TYO:4523) blockbuster Alzheimer’s disease drug Aricept is crumbling fast with two more generics companies receiving U.S. Food and Drug Administration approval this ...

Alzheimer’s disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it’s doing any ...

(CBS/AP) Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's ...

Dear Dr. Roach: I have a friend, age 56, who was diagnosed with Alzheimer’s disease a few years ago and has been taking Aricept, which has helped immensely. Now she has begun taking medical marijuana, ...

Salzburg, Austria - Treatment with ARICEPT® (donepezil hydrochloride tablets) significantly improved the cognitive and global (overall) function of patients with vascular dementia (VaD), compared with ...

ARICEPT (donepezil HCl) 23mg tablets by Eisai The FDA has approved Eisai's Aricept (donepezil HCl tablets) in a 23mg dosage strength for the treatment of moderate-to-severe Alzheimer's disease. MPR, a ...

New warnings have been added to the prescribing information for the Alzheimer's drug Aricept (donepezil) advising of the risk of two rare but potentially serious conditions: muscle breakdown ...

March 17, 2006 — -- Doctors were not surprised to hear the news that 11 people in a clinical trial died while taking Aricept, a drug currently approved for use for patients with Alzheimer's ...

Generics maker Teva Pharmaceuticals USA Inc. has agreed to suspend litigation over a compound patent for Eisai Co. Ltd.'s popular Alzheimer's drug Aricept, effectively ending Teva's bid to manufacture ...